Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation (TMS) has been in practice since 1985. FDA has cleared its use for Major Depressive Disorder since 2008.
A number of the rTMS systems have been cleared by the Food and Drug Administration (FDA) for neuromodulation purposes, including in the treatment of Major Depressive Disorder. The neuromodulation equipment used by the MeRT treatment has been cleared by FDA in the treatment of depression and may be used off label for other disorders in the practice of medicine.
We offer Transcranial Magnetic Stimulation (TMS) cutting edge technology to treat neurological issues. We utilize the patented MeRT Treatment process as a transformative strategy to restore the entire spectrum of neurological activity from sensorimotor to cognitive.